BOT 2.21% 33.3¢ botanix pharmaceuticals ltd

Sp trajectory post approval, page-7

  1. 4,168 Posts.
    lightbulb Created with Sketch. 5429
    It's impossible to know, but I will say this.

    If BOT can sell as many units that Kaken sold last year ( 350,000 ), that should be somewhere around 117 million AUD in profit.

    PE 36:1 = Share price around $2.50 AUD.

    Why PE 36, same as CSL, same as the startup Neuren for recurring payments. (royalties)


    Now - US 3X the population, what if they do a lot better then Kaken?

    Listed unicorn?

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
33.3¢
Change
-0.008(2.21%)
Mkt cap ! $606.3M
Open High Low Value Volume
33.5¢ 34.0¢ 33.0¢ $445.2K 1.317M

Buyers (Bids)

No. Vol. Price($)
13 408328 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 146933 4
View Market Depth
Last trade - 10.58am 10/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.